SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO)
CUSIP: 869367102
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 16,611,035
- Total 13F shares
- 63,167,394
- Share change
- +9,772,075
- Total reported value
- $185,075,042
- Put/Call ratio
- 13800%
- Price per share
- $2.93
- Number of holders
- 119
- Value change
- +$25,139,079
- Number of buys
- 77
- Number of sells
- 46
Quarterly Holders Quick Answers
What is CUSIP 869367102?
CUSIP 869367102 identifies STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 869367102:
Top shareholders of STRO - SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
35%
|
5,778,188
|
$32,646,762 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
34%
|
5,701,905
|
$32,215,763 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
29%
|
4,735,963
|
$26,758,191 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
25%
|
4,096,619
|
$23,145,897 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
18%
|
3,022,790
|
$17,078,763 | — | 31 Mar 2024 | |
| Kynam Capital Management, LP |
13F
|
Company |
12%
|
2,001,727
|
$11,309,758 | — | 31 Mar 2024 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
12%
|
2,000,000
|
$11,300,000 | — | 31 Mar 2024 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
11%
|
1,846,906
|
$10,435,019 | — | 31 Mar 2024 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
11%
|
1,790,051
|
$10,113,788 | — | 31 Mar 2024 | |
| Samsara BioCapital, LLC |
13F
|
Company |
10%
|
1,675,579
|
$9,467,021 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
7.9%
|
1,308,884
|
$7,395,195 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
7.7%
|
1,286,316
|
$7,268,472 | — | 31 Mar 2024 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
7.2%
|
1,204,253
|
$6,803,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
7.2%
|
1,196,723
|
$6,761,485 | — | 31 Mar 2024 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
7%
|
1,165,466
|
$6,584,883 | — | 31 Mar 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
6.8%
|
1,123,100
|
$6,345,515 | — | 31 Mar 2024 | |
| Eversept Partners, LP |
13F
|
Company |
6.6%
|
1,091,419
|
$6,166,517 | — | 31 Mar 2024 | |
| JACOBS LEVY EQUITY MANAGEMENT, INC |
13F
|
Company |
6.4%
|
1,069,522
|
$6,042,799 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
4.8%
|
802,735
|
$4,535,453 | — | 31 Mar 2024 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
4.7%
|
785,204
|
$4,436,403 | — | 31 Mar 2024 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
4%
|
671,100
|
$3,791,715 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
3.3%
|
549,366
|
$3,103,919 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
2.9%
|
486,384
|
$2,748,069 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.9%
|
485,797
|
$2,745,000 | — | 31 Mar 2024 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
2.9%
|
485,764
|
$2,744,567 | — | 31 Mar 2024 | |
| S.c.a. Candriam |
13F
|
Individual |
2.7%
|
440,422
|
$2,488,384 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.1%
|
340,741
|
$1,925,187 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
2%
|
337,628
|
$1,907,598 | — | 31 Mar 2024 | |
| DAFNA Capital Management LLC |
13F
|
Company |
2%
|
334,079
|
$1,887,546 | — | 31 Mar 2024 | |
| Verition Fund Management LLC |
13F
|
Company |
1.7%
|
283,621
|
$1,602,459 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.7%
|
275,700
|
$1,557,705 | — | 31 Mar 2024 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
1.6%
|
260,696
|
$1,472,932 | — | 31 Mar 2024 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
1.5%
|
255,057
|
$1,441,072 | — | 31 Mar 2024 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.5%
|
241,643
|
$1,365,283 | — | 31 Mar 2024 | |
| Fisher Asset Management, LLC |
13F
|
Company |
1.2%
|
196,517
|
$1,110,321 | — | 31 Mar 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
1.2%
|
195,000
|
$1,101,750 | — | 31 Mar 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
1.2%
|
194,418
|
$1,098,462 | — | 31 Mar 2024 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
1.2%
|
193,671
|
$1,094,241 | — | 31 Mar 2024 | |
| Man Group plc |
13F
|
Company |
1.1%
|
190,633
|
$1,077,076 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.1%
|
184,685
|
$1,043,470 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.97%
|
160,876
|
$908,949 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.9%
|
149,005
|
$841,878 | — | 31 Mar 2024 | |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC |
13F
|
Company |
0.76%
|
126,459
|
$714,493 | — | 31 Mar 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.72%
|
120,000
|
$678,000 | — | 31 Mar 2024 | |
| FMR LLC |
13F
|
Company |
0.68%
|
112,322
|
$634,619 | — | 31 Mar 2024 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.67%
|
111,955
|
$632,547 | — | 31 Mar 2024 | |
| Jump Financial, LLC |
13F
|
Company |
0.67%
|
111,197
|
$628,263 | — | 31 Mar 2024 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.59%
|
98,227
|
$554,983 | — | 31 Mar 2024 | |
| PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO |
13F
|
Company |
0.58%
|
96,657
|
$546,112 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.57%
|
94,164
|
$532,017 | — | 31 Mar 2024 |
Institutional Holders of SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) as of Q2 2024
As of 30 Jun 2024,
SUTRO BIOPHARMA, INC. - Common Stock, par value $0.001 per share (STRO) was held by
119 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,167,394 shares.
The largest 10 holders included
SUVRETTA CAPITAL MANAGEMENT, LLC, BlackRock Inc., Point72 Asset Management, L.P., MILLENNIUM MANAGEMENT LLC, VANGUARD GROUP INC, MPM BIOIMPACT LLC, Samsara BioCapital, LLC, Kynam Capital Management, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., and BAILLIE GIFFORD & CO.
This page lists
119
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
116
Q2 2024 holders
119
Holder diff
3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.